Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Central nervous system relapse is uncommon after chimeric antigen receptor T-cell therapy for relapsed/refractory large B-cell lymphoma

Blood (2025) 146 (Supplement 1): 5497.

https://doi.org/10.1182/blood-2025-5497

Published: 2025

Journal Articles

Importance of Early Rescue and Relative Dose-Intensity in the Salvage Therapy with Tafasitamab-Lenalidomide in Diffuse Large B-Cell Lymphoma: Real-Life Study in Spain (GELTAMO)

Antonio Gutiérrez, Izaskun Zeberio, Pilar Martinez-Barranco, Francisco Javier Peñalver, Sandra Pérez, Daniel Morillo, Xabier Mart N Martitegui, Concepción Nicolás, Ainara Ferrero, Ana Jiménez Ubieto, Mariana Bastos-Oreiro, Julio Dávila-Valls, Maria Victoria Calle Gordo, María Pérez Sala, Guillermo Rodríguez Garcia, Aranzazu Alonso Alonso, Ana Garcia Noblejas, Diana Sanchez Arguello, Teresa Knight Asorey, Maria Angeles Fernandez Fernandez, Javier López Marin, Jaime Perez de Oteyza, Sonia González De Villambrosia, Elena Perez Ceballos, Alejandro Marin, Belén Navarro, Ruben Fernandez Alvarez, Pilar Gómez, Jose Antonio Hueso, Maria Jesus Penarrubia Ponce, Pilar Bravo, Daniel García Belmonte, Haridian De La Nuez Melian, Sara Nistal, Pau Abrisqueta Costa, Fernanda Ibañez, Luis Palomera, Eva Donato, Andrea Provencio Rincon, Maria Stefania Infante, Eva Gonzalez Barca

Blood (2024) 144 (Supplement 1): 2356.

https://doi.org/10.1182/blood-2024-210868

Published: 2024

Journal Articles

Real World Evidence of Second Line Therapy in Relapsed/Refractory Large B Cell Lymphoma: Spanish Multicenter Geltamo Study

Blood (2024) 144 (Supplement 1): 1715.

https://doi.org/10.1182/blood-2024-199742

Published: 2024

Journal Articles

Avatrombopag Use in Patients with Persistent Thrombocytopenia Secondary to Intensive Chemotherapy Treatment

Aser Alonso Carballo, Marta Lopez Lopez-Cepero, Maria Jimenez Moya, Sandra Pérez, Lucia García Mañó, Jose Maria Sanchez Raga, Aina Oliver Caldes, Leyre Bento De Miguel, Andres Novo Garcia, Guiomar Puget Juan, Bernat Galmes Sureda, Antonio Palomero Massanet, Carlos Fernández de Larrea, Antonia Sampol Mayol, Mariana Canaro Hinryk

Blood (2024) 144 (Supplement 1): 5445.

https://doi.org/10.1182/blood-2024-210402

Published: 2024

Journal Articles

Survival Outcomes in Patients with Intermediate Risk Acute Myeloid Leukemia: A Single-Center Retrospective Review

Lucia Garcia Mañó, Sandra Pérez, Bernardo López Andrade, MD, Maria Antonia Duran Pastor, Andrés Novo, MD, Antonio Gutiérrez, Antonia Sampol

Blood (2019) 134 (Supplement_1): 5112.

https://doi.org/10.1182/blood-2019-131987

Published: 2019

Journal Articles

Analysis of Micro-RNAs Associated to Treatment Failure in Diffuse Large B Cell Lymphoma

Blood (2019) 134 (Supplement_1): 1627.

https://doi.org/10.1182/blood-2019-130544

Published: 2019

Journal Articles

Long Term Follow-up in Mantle Cell Lymphoma Patients Treated with R-GemOx Followed By Consolidation and Rituximab Maintenance

Marta Garcia Recio, Leyre Bento, MD, Sandra Pérez-León, Sara Aida Jiménez-Julià, Jordi Gines, Jordi Martínez-Serra, PhD, Antonia Sampol, MD PhD, Antonio Gutiérrez, MD PhD

Blood (2018) 132 (Supplement 1): 5337.

https://doi.org/10.1182/blood-2018-99-119713

Published: 2018

Journal Articles

Identification of Patients with Follicular Lymphoma Patients at Risk of Failing Frontline Immunochemotherapy and Rituximab Maintenance

Marta Garcia Recio, Sandra Pérez-León, Leyre Bento, MD, Antonio Salar, MD PhD, Blanca Sanchez-Gonzalez, Jordi Gines, Beatriz Robredo, Lucia García, Sara Aida Jiménez-Julià, Jordi Martínez-Serra, PhD, Antonia Sampol, MD PhD, Antonio Gutiérrez, MD PhD

Blood (2018) 132 (Supplement 1): 5339.

https://doi.org/10.1182/blood-2018-99-119551

Published: 2018

Journal Articles

R-CHOP with or without Lenalidomide/Bortezomib As a First Line Treatment for Patients with Non-Germinal Center Diffuse Large B Cell Lymphoma (DLBCL) Subtype: Son Espases University Hospital Experience

Sara Aida Jiménez-Julià, Leyre Bento, MD, Adriana Marcela Quintero, Marta Garcia Recio, Jordi Martínez-Serra, PhD, Francesc Mestre, Lucia García, Sandra Pérez, Gaspar Aspas, Paloma López Perezagua, Jaume Daumal, Rafael Ramos, Antonia Sampol, MD PhD, Antonio Gutiérrez, MD PhD

Blood (2018) 132 (Supplement 1): 1710.

https://doi.org/10.1182/blood-2018-99-119138

Published: 2018

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Central nervous system relapse is uncommon after chimeric antigen receptor T-cell therapy for relapsed/refractory large B-cell lymphoma

Importance of Early Rescue and Relative Dose-Intensity in the Salvage Therapy with Tafasitamab-Lenalidomide in Diffuse Large B-Cell Lymphoma: Real-Life Study in Spain (GELTAMO)

Real World Evidence of Second Line Therapy in Relapsed/Refractory Large B Cell Lymphoma: Spanish Multicenter Geltamo Study

Avatrombopag Use in Patients with Persistent Thrombocytopenia Secondary to Intensive Chemotherapy Treatment

Survival Outcomes in Patients with Intermediate Risk Acute Myeloid Leukemia: A Single-Center Retrospective Review

Analysis of Micro-RNAs Associated to Treatment Failure in Diffuse Large B Cell Lymphoma

Long Term Follow-up in Mantle Cell Lymphoma Patients Treated with R-GemOx Followed By Consolidation and Rituximab Maintenance

Identification of Patients with Follicular Lymphoma Patients at Risk of Failing Frontline Immunochemotherapy and Rituximab Maintenance

R-CHOP with or without Lenalidomide/Bortezomib As a First Line Treatment for Patients with Non-Germinal Center Diffuse Large B Cell Lymphoma (DLBCL) Subtype: Son Espases University Hospital Experience

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only